* Inspire Medical Systems Inc INSP.N reported a quarterly
adjusted loss of 53 cents per share for the quarter ended in
March. The mean expectation of thirteen analysts for the quarter
was for a loss of 66 cents per share.
* Revenue rose 84.3% to $127.90 million from a year ago;
analysts
expected $119.30 million.
* Inspire Medical Systems Inc's reported EPS for the quarter
was a
loss of 53 cents.
* The mean earnings estimate of analysts had risen by
about 31.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Inspire Medical Systems Inc shares had risen by 12.0% this
quarter and gained 4.1% so far this year.
* The company reported a quarterly loss of $15.42 million.
* Wall Street's median 12-month price target for Inspire
Medical
Systems Inc is $304.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
2 at 10:02 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.66 -0.53 Beat
Dec. 31 2022 -0.57 0.10 Beat
Sep. 30 2022 -0.77 -0.60 Beat
Jun. 30 2022 -0.62 -0.53 Beat